(VIANEWS) – Shares of TherapeuticsMD (NASDAQ Composite: TXMD) fell 6.26% to $0.73 at 12:20 EST on Tuesday, following the last session’s downward trend. NASDAQ Composite is jumping 0.24% to $15,141.24, after four consecutive sessions in a row of losses. This seems, up until now, a somewhat positive trend exchanging session today.
TherapeuticsMD’s last close was $0.80, 70.91% under its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 3268139 which is 40.87% below its average volume of 5527781.
TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.73 at 12:20 EST, way below its 52-week high of $2.75 and higher than its 52-week low of $0.72.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way below its 50-day moving average of $0.87 and way under its 200-day moving average of $1.15.
More news about TherapeuticsMD (TXMD).